Tubulin inhibitor 6

Tubulin inhibitor 6 (CAS No.: 105925-39-1) is a small-molecule antimitotic agent that functions as a tubulin polymerization inhibitor and exhibits potent antiproliferative activity across multiple cancer cell lines, positioning it within the class of microtubule-targeting agents widely used in oncology research. It disrupts microtubule dynamics by inhibiting tubulin assembly, with activity observed in the low micromolar range in cell-free systems, and demonstrates growth inhibitory effects in leukemia cell models such as K562 cells at submicromolar concentrations, consistent with its role in impairing mitotic progression and inducing cell death. Although initially reported in earlier studies as a modulator of protein phosphatase 2A (PP2A) complexes, subsequent investigations indicate that its primary mechanism of action is independent of direct PP2A activation and is instead attributable to microtubule destabilization. In addition to its antitumor activity, it has been shown to induce apoptosis in certain epithelial cancer cell lines and to exhibit moderate inhibitory effects on cholinesterases, suggesting potential off-target interactions at higher concentrations. Tubulin inhibitor 6 is commonly utilized in biochemical and cellular assays to study cytoskeletal dynamics, mitotic regulation, and mechanisms of drug resistance, as well as in phenotypic screening platforms for anticancer drug discovery, with experimental concentrations typically optimized according to specific cellular contexts and assay conditions.